Trade Mark Journal No.2025/047 21 November 2025

UK00004294095 13 November 2025 (5)

RAYZACT

International priority date claimed: 11 June 2025 (United States of America) (99228653)

Class 5: Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; diagnostic radiopharmaceutical preparations .

RayzeBio, Inc.

Representative: Sipara Limited